Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...
Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based detection of molecular residual disease may identify patients at high risk ...
According to reports circulating last week, the Government is set to kick into the long grass the proposal for a national ...
Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, ...
The BladderPath trial indicates that mpMRI can expedite MIBC treatment and improve bladder cancer-specific survival compared to traditional TURBT. The study showed a significant improvement in BCSS ...
Presentation of data at ESMO Congress 2025 shows MRI scanning before usual diagnostic route sped up time to treatment ...
A HALF-HOUR scan could nearly halve bladder cancer deaths, a study suggests. Giving patients an MRI scan before the usual ...
With the backing of Rishi Sunak, Prostate Cancer UK published a report to the national screening committee back in 2022 in ...
Researchers in China combined findings from MRI scans with clinical features to create a new predictive model for nonmuscle-invasive bladder cancer recurrence.
The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.
Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, ...
As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, ...